Literature DB >> 22555276

Mesenchymal stem cells.

Sara Rankin1.   

Abstract

Mesenchymal Stem cells (MSCs) are stromal cells that can be readily harvested from adult bone marrow and adipose tissue, but also umbilical cords. With respect to respiratory disease, the therapeutic potential of these cells lies in their paracrine effects which underlie their ability to enhance tissue regeneration and modulate immune responses. MSCs have been shown to be effective in a range of murine models of respiratory disease, and there are currently five clinical trials involving the administration of MSCs for respiratory diseases, including COPD and emphysema. This paper summarises the features of MSCs.

Entities:  

Mesh:

Year:  2012        PMID: 22555276     DOI: 10.1136/thoraxjnl-2012-201923

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  6 in total

Review 1.  Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

Authors:  Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2013-10

Review 2.  The clinical use of regenerative therapy in COPD.

Authors:  Roberto Lipsi; Paola Rogliani; Luigino Calzetta; Andrea Segreti; Mario Cazzola
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-12-12

3.  Immunoregulation of Bone Marrow-Derived Mesenchymal Stem Cells on the Chronic Cigarette Smoking-Induced Lung Inflammation in Rats.

Authors:  Xiaoyan Li; Junyan Wang; Jing Cao; Lijuan Ma; Jianying Xu
Journal:  Biomed Res Int       Date:  2015-11-18       Impact factor: 3.411

4.  Acceleration of wound healing in acute full-thickness skin wounds using a collagen-binding peptide with an affinity for MSCs.

Authors:  Huili Wang; Xin Yan; Liangyun Shen; Shiyan Li; Yue Lin; Shuqin Wang; Xiang Lin Hou; Chunying Shi; Yun Yang; Jianwu Dai; Qian Tan
Journal:  Burns Trauma       Date:  2014-10-25

5.  Clinical applications of mesenchymal stem cells in chronic lung diseases.

Authors:  Katerina M Antoniou; Konstantinos Karagiannis; Eliza Tsitoura; Eleni Bibaki; Ismini Lasithiotaki; Athanasia Proklou; Demetrios A Spandidos; Nikos Tzanakis
Journal:  Biomed Rep       Date:  2018-02-16

6.  Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?

Authors:  Fanny Loisel; Bastien Provost; François Haddad; Julien Guihaire; Myriam Amsallem; Bojan Vrtovec; Elie Fadel; Georges Uzan; Olaf Mercier
Journal:  Pulm Circ       Date:  2018-02-26       Impact factor: 3.017

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.